In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Interesting Published Articles on Stroke

These recently published articles have been specifically selected to be of interest to Council on Stroke Members.

Stroke


  1. Anticoagulation use and clinical outcomes after major bleeding on dabigatran or warfarin in atrial fibrillation. Stroke 2017;48:159–66.Hernandez I, Zhang Y, Brooks MM, et al.
  2. Resumption of anticoagulation after major bleeding decreases the risk of stroke in patients with atrial fibrillation. Stroke 2017, vol. 22, issue 3, 2017, p. 107-108. Marcelle D Smit, Isabelle C Van Gelder 
  3. Subclinical Atrial Fibrillation in Older Patients.
    Healey JS, Alings M, Ha AC, Leong-Sit P, Birnie DH, de Graaf JJ, Freericks M, Verma A, Wang J, Leong D, Dokainish H, Philippon F, Barake W, McIntyre WF, Simek KD, Hill MD, Mehta SR, Carlson M, Smeele F, Pandey AS, Connolly SJ; ASSERT-2 Investigators
    Circulation. 2017 Aug 4. pii: CIRCULATIONAHA.117.028845. doi: 10.1161/CIRCULATIONAHA.117.028845. [Epub ahead of print]
    PMID: 28778946
  4. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.
    Lopes RD, Alings M, Connolly SJ, Beresh H, Granger CB, Mazuecos JB, Boriani G, Nielsen JC, Conen D, Hohnloser SH, Mairesse GH, Mabo P, Camm AJ, Healey JS.
    Am Heart J. 2017 Jul;189:137-145. doi: 10.1016/j.ahj.2017.04.008. Epub 2017 Apr 24.
    PMID: 28625370
  5. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.
    Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin LÅ, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP; AF-Screen Collaborators.
    Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693. Review.
    PMID: 28483832
  6. Female gender as a risk factor for stroke associated with atrial fibrillation.
    Camm AJ, Savelieva I.
    Eur Heart J. 2017 May 14;38(19):1480-1484. doi: 10.1093/eurheartj/ehx103. No abstract available.
    PMID: 28369302
  7. The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review.
    Paul L. Hess, MD, MHS1,2; Jeff S. Healey, MD, MSc3; Christopher B. Granger, MD4; et al
  8. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.
    Healey JS et al.
  9. AF screen International Collaboration.
    Freedman B.
  10. Stroke prevention in Atrial fibrillation.
    Freedman B, Potpara TS, Lip GY.
  11. Atrial high rate episodes and stroke prevention.
    Camm et al.
  12. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.
    Bassand JP et al.
  13. Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary. Heidbuchel H et al. Euro Heart J 2016.
  14. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
    Connolly SJ et al.
  15. Global Survey of the Frequency of Atrial Fibrillation-Associated Stroke: Embolic Stroke of Undetermined Source Global Registry.
    Perera et al.